3852.ai
Biotechnology ResearchVermont, United States2-10 Employees
3852.ai creates combination therapies for hard to treat diseases using predictive artificial intelligence, automated design of experiments, and robotics.
Innovative AI Focus 3852.ai leverages advanced artificial intelligence for designing combination therapies, indicating a strong emphasis on cutting-edge technology which could benefit from AI-enhanced solutions and partnerships.
Niche Therapeutic Area Specializing in hard-to-treat diseases, the company operates in a highly specialized segment, presenting opportunities to provide targeted biotech tools, funding, or collaborative research support.
Growing Revenue Scale With revenues ranging from 1 million to 10 million dollars, 3852.ai shows promising financial growth, making it an attractive partner for technology vendors or investors looking to expand in biotech.
Tech Infrastructure Utilizing platforms like Squarespace, Google Workspace, and Google Analytics, the company maintains a modern digital presence, presenting opportunities for digital marketing, analytics, or cloud solution providers to add value.
Small but Niche Team Operating with a small team of 2-10 employees, 3852.ai is likely lean and agile, open to innovative software tools, research partnerships, and consultancy services that can enhance their capabilities.
3852.ai uses 6 technology products and services including Squarespace, Cart Functionality, Google Workspace, and more. Explore 3852.ai's tech stack below.
| 3852.ai Email Formats | Percentage |
| Last@3852.ai | 50% |
| Last@3852.ai | 50% |
Biotechnology ResearchVermont, United States2-10 Employees
3852.ai creates combination therapies for hard to treat diseases using predictive artificial intelligence, automated design of experiments, and robotics.
3852.ai's revenue is estimated to be in the range of $1M$10M
3852.ai's revenue is estimated to be in the range of $1M$10M